immunology

Health By Megan Molteni

‘Just stupid stuff’: Logistics and lack of testing stymied finding the Omicron variant in the U.S.

Pharmalot By Ed Silverman

Former Immunomedics executives are charged with insider trading

Politics By Nicholas Florko

Califf, nominee to lead FDA, asks Woodcock to stay in leadership role if he’s confirmed

Health Tech By Katie Palmer

Virtual care companies rush to ease access to Covid-19 antivirals

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Carlos del Rio on Covid antivirals, an FDA conundrum, & the rise of Omicron

Politics By Rachel Cohrs

Hospitals and doctors fail to stop end-of-year Medicare cuts, for now

Health By Andrew Joseph

Second U.S. case of Omicron variant indicates domestic transmission

In the Lab By Megan Molteni

Most advanced lab-grown human embryos prompt a pressing question: Are they getting too real?